The World Health Organization (WHO) has announced that they plan on replicating Moderna’s COVID-19 vaccine to boost COVID-19 vaccination rates and production in Africa. Although efforts have yet to yield results, the plans will allow for more developing countries to gain access to COVID-19 vaccinations as the year’s supply so far has been disproportionately bought by more developed nations. Moderna announced that it does not plan on enforcing patents associated with its vaccine, although so far, the company has not reached a production deal with the World Health Organization-backed tech transfer hub in South Africa. According to the African Union’s top health official, only 3% of Africans have received vaccinations currently.
Read more here.